Ambu A/S Stock
Stocks
AMBU B
DK0060946788
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Nasdaq Copenhagen
11:20:00 2026-09-28 EDT
|
5-day change | 1st Jan Change | ||
| 69.25 DKK | +1.54% |
|
+7.12% | -21.31% |
| 09-25 | Ambu receives approvals for expanded use of GI endoscope | FW |
| 09-21 | Ambu Concludes DKK300 Million Share Buyback Program | MT |
| Market Cap | 18.08B 2.75B 2.42B 2.29B 2.07B 3.9B 264B 3.92B 27.38B 10.57B 135B 10.32B 10.1B 433B | P/E 2026 * |
29x | P/E 2027 * | 22.8x |
|---|---|---|---|---|---|
| Enterprise Value | 17.44B 2.65B 2.33B 2.21B 2B 3.76B 255B 3.78B 26.41B 10.2B 130B 9.96B 9.74B 417B | EV / Sales 2026 * |
2.71x | EV / Sales 2027 * | 2.42x |
| Free-Float |
86.18% | Yield 2026 * |
0.68% | Yield 2027 * | 0.83% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Copenhagen
| AMBU B | Delayed | |
CBOE
| AMBUBc | Real-time | |
|
OTC Markets
| AMBFF | Delayed | |
|
Tradegate
| 547A | Real-time | |
|
Boerse Muenchen
| 547A | Real-time | |
|
CBOE
| 0MJF | Real-time | |
|
London S.E.
| 0MJF | Delayed | |
|
Deutsche Boerse AG
| 547A | Delayed | |
|
Börse Stuttgart
| 547A | Delayed | |
|
Wiener Boerse
| AMBU | End-of-day quote |
Last Transcript: Ambu A/S
| 1 day | +1.54% | ||
| 1 week | +7.12% | ||
| Current month | -2.67% | ||
| 1 month | -1.77% | ||
| 3 months | +13.62% | ||
| 6 months | +2.37% | ||
| Current year | -21.31% |
| 1 week | 64.85 |  | 70.2 |
| 1 month | 64.2 | | 72.45 |
| Current year | 56.25 | | 92.15 |
| 1 year | 56.25 | | 111.8 |
| 3 years | 56.25 | | 154.6 |
| 5 years | 56.25 | | 201.7 |
| 10 years | 52 | | 358.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 2022-05-19 | |
| Director of Finance/CFO | 42 | 2023-12-31 | |
| Chief Operating Officer | 53 | 2024-06-09 |
| Director | Title | Age | Since |
|---|---|---|---|
Jørgen Jensen
CHM | Chairman | 58 | 2020-12-08 |
Susanne Larsson
BRD | Director/Board Member | 58 | 2021-12-13 |
| Director/Board Member | 63 | 2021-12-13 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 12/4/25 | Buy | Chief Financial Officer | 10,500 | 0.0045% | ||
| 11/7/25 | Buy | Chief Executive Officer | 20,000 | 0.0583% | ||
| 11/7/25 | Buy | Chief Executive Officer | 20,000 | 0.0583% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.54% | +7.12% | -25.70% | -4.59% | 2.75B | |
| -0.31% | -1.94% | -24.39% | +2.91% | 175B | |
| +0.97% | -2.45% | -5.01% | +13.74% | 114B | |
| -1.01% | -4.01% | -1.04% | +66.14% | 57.98B | |
| +0.01% | +1.73% | -0.42% | -30.03% | 50.07B | |
| -1.56% | -0.19% | +13.60% | +50.70% | 50.13B | |
| +0.07% | -2.79% | +29.18% | -9.20% | 32.71B | |
| +1.07% | +9.73% | - | - | 30.77B | |
| +1.41% | +3.83% | +43.64% | -0.90% | 26.44B | |
| +1.98% | +7.44% | +26.26% | -1.90% | 23.96B | |
| Average | +0.42% | +2.14% | +6.24% | +9.65% | 56.4B | |
| Weighted average by Cap. | +0.08% | -0.14% | -2.94% | +12.32% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.43B 978M 860M 813M 738M 1.39B 93.89B 1.39B 9.74B 3.76B 47.91B 3.67B 3.59B 154B | 7.13B 1.09B 954M 902M 819M 1.54B 104B 1.55B 10.81B 4.17B 53.15B 4.07B 3.99B 171B |
| Net income | 632M 96.09M 84.51M 79.91M 72.48M 136M 9.22B 137M 957M 370M 4.71B 361M 353M 15.12B | 797M 121M 107M 101M 91.39M 172M 11.63B 173M 1.21B 466M 5.93B 455M 445M 19.07B |
| Net Debt | -642M -97.65M -85.88M -81.21M -73.66M -138M -9.37B -139M -972M -376M -4.78B -367M -359M -15.37B | -778M -118M -104M -98.4M -89.25M -168M -11.36B -169M -1.18B -455M -5.8B -444M -435M -18.62B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-28 | DKK 69.25 | +1.54% | 588,183 |
| 26-09-25 | DKK 68.20 | -1.09% | 406,020 |
| 26-09-24 | DKK 68.95 | +2.00% | 975,301 |
| 26-09-23 | DKK 67.60 | +3.84% | 745,434 |
| 26-09-22 | DKK 65.10 | +0.70% | 1,072,156 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMBU B Stock
Select your edition
All financial news and data tailored to specific country editions
